ArticleCancer cell international2025
Comprehensive analysis reveals CLDN9 is a new biomarker in human cancers and immunotherapeutic target for glioblastoma multiforme.
Yuanyuan Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.